menopause

Untreated hot flashes may impact work productivityMany women who suffer from moderate to severe vasomotor symptoms (VMS) appear to go untreated, potentially leading to work loss, according to a new study in Menopause.
Benefits and risks of postmenopausal hormone therapy: Two expert opinions
Benefits and risks of postmenopausal hormone therapy: Two expert opinionsThe initial findings from the WHI were concerning, but subsequent detailed analysis and long-term follow-up of women enrolled in these trials have brought perspective.
Ultrasound triage of women with postmenopausal bleeding
Ultrasound triage of women with postmenopausal bleedingUltrasound-based evaluation is less costly than an endometrial biopsy and also allows for evaluation of the adnexa and bladder.
Caffeine may fuel hot flashesMenopausal hot flashes may be more bothersome in women who drink caffeine, according to results of a 6-year cross-sectional survey published in Menopause.
What’s the impact of hormone therapy on heart health?According to a recent study in Annals of Internal Medicine, hormonal therapy in early menopause may improve some markers of cardiovascular disease (CVD) risk, but not progression of atherosclerosis.
Aromatase inhibitor may improve outcome in premenopausal breast cancerAdjuvant therapy combining ovarian suppression with an aromatase inhibitor—a class of drugs typically only recommended for postmenopausal patients—may be more beneficial for premenopausal patients with breast cancer than tamoxifen.
SNRI may be as effective as estrogen for hot flashesA small study led by investigators from Brigham and Women’s Hospital suggests that the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine hydrochloride may be as effective as low-dose estradiol for relief of hot flashes.
Early menopause tied to heart failureAccording to a recent study in Menopause, women who go through natural menopause at ages 40 to 45 may be at increased risk of developing heart failure and smoking may produce a similar risk among those who experience menopause at ages 46 to 49.
Premature menopause associated with risk of lower cognitive functionEarly menopause—whether natural or surgical—may be associated with negative effects on cognitive function that are not entirely offset by postmenopausal hormone therapy (HT), according to a new study in BJOG.
Heavy or prolonged bleeding in menopause is not uncommon
Heavy or prolonged bleeding in menopause is not uncommonWomen undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.